Life sciences regulatory and compliance partner Joshua Oyster will present in a webinar hosted by FDANews titled “FDA in 2024: What to Expect in an Election Year,” on October 26.
The U.S. Food and Drug Administration is adapting to a post-COVID environment that involves increased use of artificial intelligence, innovations in cell and gene therapies and changes in medical product development.
The webinar will analyze potential FDA policies, programs, priorities, major issues and challenges in 2024.
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.